Cell Therapy for Neonatal Hypoxic–Ischemic Encephalopathy
- 1 March 2010
- journal article
- review article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 19 (3) , 299-310
Abstract
Neonatal hypoxic-ischemic encephalopathy (HIE) is a common cause of long-term neurological disability in children. Despite advances in supportive care, no treatments for HIE are available at present. The potential use of stem/progenitor cell therapies for neuroprotection or regeneration of the damaged adult brain has been evaluated in several preclinical studies, and the most promising results are now being tested in clinical trials. In recent years, the use of stem/progenitor cell transplantation in animal models of HIE has also been evaluated in several laboratories. It was shown that human umbilical cord blood mononuclear cells and mesenchymal stem/progenitor cells may have a therapeutic potential through multiple mechanisms acting locally in the central nervous system and possibly in peripheral organs of hypoxic-ischemic animals. Neural stem/progenitor cells (NSCs) have also been transplanted in animal models of HIE, migrating long distances to ischemic brain areas and differentiating into neurons. The results of these studies have raised important questions that must be addressed before these findings can be translated to the bedside. In this review, we give a critical overview of the different studies published up to now, and we discuss the endogenous regenerative potential of NSCs of the newborn brain when challenged by an HIE insult. We also discuss the use of cell therapies for the encephalopathy of prematurity.Keywords
This publication has 82 references indexed in Scilit:
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer diseaseProceedings of the National Academy of Sciences, 2009
- Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal ratsExperimental Neurology, 2009
- Brain injury in premature infants: a complex amalgam of destructive and developmental disturbancesThe Lancet Neurology, 2009
- Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell deathJournal of Neuroscience Research, 2008
- Neonatal hypoxic/ischemic brain injury induces production of calretinin‐expressing interneurons in the striatumJournal of Comparative Neurology, 2008
- Intravenous Grafts Recapitulate the Neurorestoration Afforded by Intracerebrally Delivered Multipotent Adult Progenitor Cells in Neonatal Hypoxic-Ischemic RatsJournal of Cerebral Blood Flow & Metabolism, 2008
- Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injuryAnnals of Neurology, 2008
- Leukemia inhibitory factor participates in the expansion of neural stem/progenitors after perinatal hypoxia/ischemiaNeuroscience, 2007
- RETRACTED: Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia–ischemia in ratsBrain Research, 2007
- Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic–ischemic brain injuryExperimental Neurology, 2006